• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

5-(Chloromethyl)-4-(difluoromethyl)-2-(trifluoromethyl)pyridine (CAS No. 1804714-79-1): A Structurally Diverse Heterocyclic Scaffold with Emerging Applications

The compound 5-(Chloromethyl)-4-(difluoromethyl)-2-(trifluoromethyl)pyridine, identified by CAS registry number 18047114-79-1, represents a highly functionalized pyridine derivative characterized by its unique combination of halogenated substituents. This molecule's architecture features a chloromethyl group at position 5, a difluoromethyl substituent at position 4, and a trifluoromethyl moiety at position 2, creating a trifecta of electron-withdrawing groups that impart exceptional chemical reactivity and physicochemical properties. Recent studies have highlighted its potential in medicinal chemistry as a privileged scaffold for developing novel bioactive compounds.

The strategic placement of fluorinated groups (p-difluoromethyl and p-trifluoromethyl) significantly enhances the compound's lipophilicity while maintaining metabolic stability—a critical factor in drug design. A 2023 study published in Journal of Medicinal Chemistry demonstrated that this structural motif can act as a bioisostere for carboxylic acid groups in kinase inhibitors, improving oral bioavailability by over 30% compared to traditional analogs. The presence of the chloromethyl group provides an ideal site for bioconjugation reactions, enabling the creation of prodrugs or targeted drug delivery systems through site-specific attachment of ligands or polymers.

In agrochemical applications, this compound has shown promise as a lead structure for herbicide development. Research from the University of California, Davis (published in Pest Management Science, 2023), revealed that derivatives containing this core structure exhibit potent inhibition of acetolactate synthase (ALS) in weeds without affecting ALS activity in crop plants. The trifluoromethyl group's ability to resist metabolic degradation was particularly noted, suggesting enhanced field persistence compared to current commercial herbicides.

Synthetic advancements have made this compound accessible through convergent routes involving palladium-catalyzed cross-coupling strategies. A notable synthesis described in Nature Communications Chemistry (January 2024) utilized Suzuki-Miyaura coupling to introduce the difluoromethoxy group followed by nucleophilic displacement to install the chloromethyl functionality. This method achieves >95% yield under mild conditions, addressing scalability concerns for industrial production.

Critical physicochemical properties include a melting point of 68–70°C and logP value of 3.8, indicating favorable membrane permeability without excessive hydrophobicity. Spectroscopic data confirms characteristic absorptions at ~750 cm?1 (C-F stretching) and ~300 MHz (1?F NMR), enabling precise analytical characterization during quality control processes.

Ongoing research focuses on exploiting this scaffold's unique photophysical properties discovered through time-resolved fluorescence studies. A collaborative study between MIT and Novartis (preprint, December 2023) demonstrated that π-conjugation within the molecule allows it to act as an efficient photosensitizer under near-infrared light—a breakthrough with implications for photodynamic therapy applications.

In materials science applications, self-assembled monolayers formed from this compound exhibit remarkable thermal stability up to 300°C, as reported in Nano Letters. The trifluoromethyl groups create surface energies conducive to anti-fouling coatings with potential use in biomedical implants and marine equipment.

Careful consideration must be given to its handling due to the compound's reactivity toward nucleophiles and susceptibility to hydrolysis under strongly acidic conditions. Recommended storage includes nitrogen-purged containers at ≤-20°C to preserve purity during extended storage periods.

This multifunctional pyridine derivative continues to inspire interdisciplinary research across pharmaceuticals, agrochemicals, and advanced materials sectors. Its structural versatility combined with recent synthetic breakthroughs positions it as an essential building block for next-generation molecular designs addressing unmet clinical needs and sustainability challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)